1-deoxynojirimycin has been researched along with Bone Diseases, Metabolic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hachulla, E; Javier, RM | 1 |
Elstein, D; HrebĂcek, M; Pastores, GM; Zimran, A | 1 |
2 review(s) available for 1-deoxynojirimycin and Bone Diseases, Metabolic
Article | Year |
---|---|
[Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aged; Aged, 80 and over; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Child; Child, Preschool; Clinical Trials as Topic; Diphosphonates; Enzyme Inhibitors; Fractures, Bone; Gaucher Disease; Glucosylceramidase; Glycoside Hydrolase Inhibitors; Humans; Joint Diseases; Kyphosis; Magnetic Resonance Imaging; Middle Aged; Osteoarthritis; Osteonecrosis; Osteoporosis; Radionuclide Imaging; Spinal Fractures; Tomography, X-Ray Computed | 2007 |
Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
Topics: 1-Deoxynojirimycin; Adult; Bone Density; Bone Diseases, Metabolic; Enzyme Inhibitors; Female; Gaucher Disease; Glucosyltransferases; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pain; Pain Measurement; Time Factors; Treatment Outcome | 2007 |